MicroRNAs as new player in rheumatoid arthritis

Joint Bone Spine

Volumn 78, Issue 1, 2011, Pages 17-22

  Duroux Richard, Isabelle ^a,b   Presumey, Jessy ^a,b   Courties, Gabriel ^a,b   Gay, Steffen ^c   Gordeladze, Jan ^a,b   Jorgensen, Christian ^a,b,d   Kyburz, Diego ^c   Apparailly, Florence ^a,b,d  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

Autoimmunity; Biomarkers; Inflammation; MicroRNA; Rheumatoid arthritis

Indexed keywords

MICRORNA; T LYMPHOCYTE RECEPTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; SHORT SURVEY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; INFLAMMATION; MICRORNAS;

EID: 78651108987     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.06.003     Document Type: Short Survey

References (60)

1. Pulikkan J.A., Dengler V., Peramangalam P.S., et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115(9):1768-1778.
2. Taganov K.D., Boldin M.P., Chang K.J., et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103(33):12481-12486.
3. Androulidaki A., Iliopoulos D., Arranz A., et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31(2):220-231.
4. Luers A.J., Loudig O.D., Berman J.W. MicroRNAs are expressed and processed by human primary macrophages. Cell Immunol 2010, 263(1):1-8.
5. Malumbres R., Sarosiek K.A., Cubedo E., et al. Differentiation-stage-specific expression of microRNAs in B-lymphocytes and diffuse large B-cell lymphomas. Blood 2008, 113(16):3754-3764.
6. Sonkoly E., Stahle M., Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008, 18(2):131-140.
7. Chen C.Z., Li L., Lodish H.F., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303(5654):83-86.
8. Thai T.H., Calado D.P., Casola S., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316(5824):604-608.
9. Teng G., Hakimpour P., Landgraf P., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28(5):621-629.
10. Xiao C., Srinivasan L., Calado D.P., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008, 9(4):405-414.
11. Li Q.J., Chau J., Ebert P.J., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129(1):147-161.
12. Hezova R, Slaby O, Faltejskova P, et al. MicroRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol 2010;260(2):70-4.
13. Lu L.F., Thai T.H., Calado D.P., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30(1):80-91.
14. Du C., Liu C., Kang J., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009, 10(12):1252-1259.
15. Zhou X., Jeker L.T., Fife B.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008, 205(9):1983-1991.
16. Liston A., Lu L.F., O'Carroll D., et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008, 205(9):1993-2004.
17. Bhanji R.A., Eystathioy T., Chan E.K., et al. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol 2007, 125(3):247-256.
18. Glinsky G.V. SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways. Cell Cycle 2008, 7(22):3564-3576.
19. Nagata Y., Nakasa T., Mochizuki Y., et al. Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a. Arthritis Rheum 2009, 60(9):2677-2683.
20. Cimmino A., Calin G.A., Fabbri M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102(39):13944-13949.
21. Yue J., Tigyi G. Conservation of miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome 2010, 21(1-2):88-94.
22. Pauley K.M., Satoh M., Chan A.L., et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10(4):R101.
23. Murata K., Yoshitomi H., Tanida S., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010, 12(3):R86.
24. El Gazzar MA, McCall CE. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem 2010;285(27):20940-51.
25. Nakamachi Y., Kawano S., Takenokuchi M., et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009, 60(5):1294-1304.
26. Lindenblatt C., Schulze-Osthoff K., Totzke G. IkappaBzeta expression is regulated by miR-124a. Cell Cycle 2009, 8(13):2019-2023.
27. Baroukh N.N., Van Obberghen E. Function of microRNA-375 and microRNA-124a in pancreas and brain. Febs J 2009, 276(22):6509-6521.
28. Le M.T., Teh C., Shyh-Chang N., et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009, 23(7):862-876.
29. O'Neill L.A. Boosting the brain's ability to block inflammation via microRNA-132. Immunity 2009, 31(6):854-855.
30. Lagos D., Pollara G., Henderson S., et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 2010, 12(5):513-519.
31. Nakasa T., Miyaki S., Okubo A., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58(5):1284-1292.
32. Stanczyk J., Pedrioli D.M., Brentano F., et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008, 58(4):1001-1009.
33. Li J., Wan Y., Guo Q., et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12(3):R81.
34. Guo M., Mao X., Ji Q., et al. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol Cell Biol 2010, 88(5):555-564.
35. Curtale G., Citarella F., Carissimi C., et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115(2):265-273.
36. Hou J., Wang P., Lin L., et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183(3):2150-2158.
37. Jazdzewski K., Murray E.L., Franssila K., et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2008, 105(20):7269-7274.
38. Tang Y., Luo X., Cui H., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signalling proteins. Arthritis Rheum 2009, 60(4):1065-1075.
39. Jurkin J, Schichl YM, Koeffel R, et al. miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. J Immunol 2010;184(9):4955-65.
40. Bhaumik D., Scott G.K., Schokrpur S., et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL. Aging (Albany NY) 2009, 1(4):402-411.
41. McCoy C.E., Sheedy F.J., Qualls J.E., et al. IL-10 inhibits miR-155 induction by Toll-like receptors. J Biol Chem 2010, 285(27):20492-20498.
42. Fulci V., Scappucci G., Sebastiani G.D., et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010, 71(2):206-211.
43. Wang J.F., Yu M.L., Yu G., et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010, 394(1):184-188.
44. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 2010, 86(3):410-420.
45. Alsaleh G., Suffert G., Semaan N., et al. Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol 2009, 182(8):5088-5097.
46. Tsai N.P., Lin Y.L., Wei L.N. Micro-RNA mir346 targets the 5'UTR of RIP140 mRNA and up-regulates its protein expression. Biochem J 2009, 424(3):411-418.
47. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105(30):10513-10518.
48. Hunter M.P., Ismail N., Zhang X., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3(11):e3694.
49. Dai Y., Huang Y.S., Tang M., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16(12):939-946.
50. Te J.L., Dozmorov I.M., Guthridge J.M., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010, 5(5):e10344.
51. Junker A., Krumbholz M., Eisele S., et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132(Pt 12):3342-3352.
52. Otaegui D., Baranzini S.E., Armananzas R., et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4(7):e6309.
53. Sonkoly E., Wei T., Janson P.C., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2007, 2(7):e610.
54. Zibert J.R., Lovendorf M.B., Litman T., et al. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010, 58(3):177-185.
55. Andersen D.C., Jensen C.H., Schneider M., et al. MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. Exp Cell Res 2010, 316(10):1681-1691.
56. Bhattacharya R., Nicoloso M., Arvizo R., et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009, 69(23):9090-9095.
57. Persson M., Andren Y., Mark J., et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 2009, 106(44):18740-18744.
58. Salerno E., Scaglione B.J., Coffman F.D., et al. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther 2009, 8(9):2684-2692.
59. Wang F., Fu X.D., Zhou Y., et al. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 2009, 42(11):725-730.
60. Xie S.Y., Li Y.J., Wang P.Y., et al. miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. Oncol Rep 2010, 23(6):1693-1700.